Genetic heterogeneity of the NS3 protease gene in hepatitis C virus genotype 1 from untreated infected patients

被引:26
作者
Vallet, S
Gouriou, S
Nousbaum, JB
Legrand-Quillien, MC
Goudeau, A
Picard, B
机构
[1] CHU Morvan, Dept Microbiol, F-29609 Brest, France
[2] Fac Med, Lab Bacteriol Virol, Brest, France
[3] CHU Cavale Blanche, Serv Hepatogastroenterol, Brest, France
[4] Univ Tours, Dept Microbiol Med & Mol, Tours, France
关键词
HCV; NS3 serine protease; quasispecies; polymorphism;
D O I
10.1002/jmv.20302
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
NS3 protease is essential for hepatitis C Virus (HCV) replication, and is one of the most promising targets for specific anti-HCV therapy. Its natural polymorphism has not been studied at the quasispecies level. In the present work, the genetic heterogeneity of the NS3 protease gene was analyzed in 17 HCV genotype 1 (5 subtypes la and 12 subtypes 1b) samples collected from infected patients before anti-viral therapy. A total of 294 clones were sequenced. Although the protease NS3 is considered to be one of the less variable genes in the HCV genome, variability of both nucleotide and amino acid sequences was found. In variants belonging to la and 1b subtypes, 224 and 267 of 543 positions showed one or more nucleotide substitutions, respectively. Forty and 74 of the 181 NS3 amino acid positions showed at least one mutation in HCV-1a and HCV-1b isolates, respectively. Most substitutions were conservative. This substantial polymorphism of the NS3 protease produced by HCV-1a and HCV-1b suggests that, despite the numerous functional and structural constraints, the enzyme is sufficiently flexible to tolerate substitutions.
引用
收藏
页码:528 / 537
页数:10
相关论文
共 59 条
[1]   Evolutionary study of HVR1 of E2 in chronic hepatitis C virus infection [J].
Alfonso, V ;
Flichman, DM ;
Sookoian, S ;
Mbayed, VA ;
Campos, RH .
JOURNAL OF GENERAL VIROLOGY, 2004, 85 :39-46
[2]  
[Anonymous], 1997, EMBnet News
[3]   The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy [J].
Bartenschlager, R .
JOURNAL OF VIRAL HEPATITIS, 1999, 6 (03) :165-181
[4]   Novel cell culture systems for the hepatitis C virus [J].
Bartenschlager, R ;
Lohmann, V .
ANTIVIRAL RESEARCH, 2001, 52 (01) :1-17
[5]   KINETIC AND STRUCTURAL-ANALYSES OF HEPATITIS-C VIRUS POLYPROTEIN PROCESSING [J].
BARTENSCHLAGER, R ;
AHLBORNLAAKE, L ;
MOUS, J ;
JACOBSEN, H .
JOURNAL OF VIROLOGY, 1994, 68 (08) :5045-5055
[6]  
Beyer BM, 2001, PROTEINS, V43, P82, DOI 10.1002/1097-0134(20010501)43:2<82::AID-PROT1020>3.0.CO
[7]  
2-4
[8]   Inhibiting viral proteases: Challenges and opportunities [J].
Bianchi, E ;
Pessi, A .
BIOPOLYMERS, 2002, 66 (02) :101-114
[9]   GENETIC ORGANIZATION AND DIVERSITY OF THE HEPATITIS-C VIRUS [J].
CHOO, QL ;
RICHMAN, KH ;
HAN, JH ;
BERGER, K ;
LEE, C ;
DONG, C ;
GALLEGOS, C ;
COIT, D ;
MEDINASELBY, A ;
BARR, PJ ;
WEINER, AJ ;
BRADLEY, DW ;
KUO, G ;
HOUGHTON, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2451-2455
[10]   Immune responses in hepatitis C: is virus or host the problem? [J].
Darling, JM ;
Wright, TL .
CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (03) :193-198